Sign in or Join FriendFeed
FriendFeed is the easiest way to share online. Learn more »
Libby's H*O*P*E*

Libby's H*O*P*E*

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education). To learn more go to http://healthinfoispower.wordpress.com.
Blog
EU Approves A Drug For Treating Ovarian Cancer ......http://www.businessinsider.com/r-eu-ag...
Phase III trial results needed before PARP inhibitor approved for ovarian cancer indication : Oncology Report......http://www.oncologypractice.com/oncolog...
Teenager with ovarian cancer turns down hysterectomy so she can still have children ......- Mirror Online - http://www.mirror.co.uk/news...
No link found between soy food and endometrial cancer risk, say researchers - News - BJOG: An International Journal of Obstetrics & Gynaecology - http://www.bjog.org/details...
2014 NCCN Guideline Updates: Experts Highlight New Recommendations for Clinical Practice - http://www.onclive.com/publica...
Mutations in Ovarian Cancer More Frequent, Varied Than Estimated ......- http://www.onclive.com/publica...
ODAC Votes Against Maintenance Olaparib in BRCA-Positive Ovarian Cancer ......- http://www.onclive.com/web-exc...
Computer-designed protein causes cancer cells’ death | UW HSNewsBeat - http://hsnewsbeat.uw.edu/story...
FDA experts spurn AstraZeneca's pitch for ovarian cancer drug olaparib......http://www.fiercebiotech.com/story...
Dallas women on 3,000 mile bike ride to raise ovarian cancer awareness ...... http://www.dallasnews.com/lifesty...
FDA staff question benefit of AstraZeneca ovarian cancer drug ......http://www.reuters.com/article...
New HIPEC treatment effectively kills ovarian cancer...... http://abc7.com/health...
Coming soon -- new treatment for ovarian cancer ..... http://www.thehealthsite.com/news...
Side effect of cancer: financial toxicity......http://www.consumeraffairs.com/news...
Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9).... [Oncology. 2014] - PubMed - NCBI - http://www.ncbi.nlm.nih.gov/pubmed...
Anti-angiopoietin therapy with trebananib (AMG 386) for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial...... The Lancet Oncology - http://www.thelancet.com/journal...
Trebananib (formally known as AMG 386; Amgen) can improve response rates (increase the rate of tumor shrinkage) and prolong the time until ovarian cancers recur. - http://medicalxpress.com/news...
Genome and Exome Sequencing DO’s and DON’Ts for Medical Professionals..... - http://www.genengnews.com/gen-new...
FDA Grants Orphan Drug Status To COTI’s Ovarian Cancer Drug COTI-2 ....- http://www.pharmaceuticalonline.com/doc...
Psioxus Kicks Off Oncolytic Vaccine Study in Ovarian Cancer......https://www.dddmag.com/news...
PSIOXUS THERAPEUTICS INITIATES ‘OCTAVE’ OVARIAN CANCER STUDY FOR ONCOLYTIC VACCINE ENADENOTUCIREV.......www.psioxus.com/downloads/2014-06_PsiOxus PR OCTAVE Study FINAL.pdf - http://www.psioxus.com/downloa...
Finding the Achilles’ Heel of Ovarian Tumor Growth......http://health.ucsd.edu/news...
Genetic pathway can slow spread of ovarian cancer ......- Robinson Research Institute - http://blogs.adelaide.edu.au/robinso...
Two Proteins Identified as Markers of Response to Neoadjuvant Chemotherapy for Ovarian Cancer.... - http://www.danburyhospital.org/News-an...
Heat being used to defeat ovarian cancer .....- http://www.8newsnow.com/story...
Combo Scores High in Ovarian Cancer, for Now...... http://www.medscape.com/viewart...
Impact of combination chemotherapy with itraconazole on survival for patients with recurrent or persistent ovarian clear cell carcinoma.... [Anticancer Res. 2014] - PubMed - NCBI - http://www.ncbi.nlm.nih.gov/pubmed...
The non-canonical Wnt ligand, Wnt5a, is upregulated and associated with epithelial to mesenchymal transition in epithelial ovarian cancer.... [Gynecol Oncol. 2014] - PubMed - NCBI - http://www.ncbi.nlm.nih.gov/pubmed...
The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.... [Oncol Rep. 2014] - PubMed - NCBI - http://www.ncbi.nlm.nih.gov/pubmed...
Inactivation of PI(3)K p110[dgr] breaks regulatory T-cell-mediated immune tolerance to cancer ...... http://www.nature.com/nature...
Other ways to read this feed:Feed readerFacebook